|
|
|
|
|
Predictive value of soluble thrombomodulin in acute renal injury induced by sepsis |
Guo Jun-chuan, Liu Qi, Xiao Dong |
Intensive Care Unit, People′s Hospital of Xinjiang Uygur Autonomous Region, Xinjiang 830000, China |
|
|
Abstract Objective Evaluate the value of endothelial injury biomarkers in predicting acute kidney injury (AKI) in patients with sepsis. Methods This study analyzed 114 sepsis patients admitted to our ICU between July 2015 and October 2017. The researchers used kidney-based criteria to improve overall prognostic creatinine in patients with AKI, including those requiring renal replacement therapy. The severity of the illness was measured by the APACHEⅡ score and the SOFA score. Statistically significant parameters in the univariate analysis were included in a Logistic regression model for multivariate analysis to determine independent predictors of AKI. Results The final 114 patients with sepsis met the inclusion and exclusion criteria, of which 63 cases non-AKI group and 51 cases with AKI group. There was no significant difference between the two groups in age, gender, BMI, infection site (P>0.05). There were significant differences in APACHEⅡ score, SOFA score, chronic renal insufficiency, septic shock, disseminated intravascular coagulation, mechanical ventilation, ICU stay, CRRT and 28-day mortality in AKI group compared with non-AKI group (P<0.05). In the endothelial markers, soluble thrombomodulin (sTM, ng/mL: 11.9±3.3 vs. 7.6±2.1, P<0.001), E-selectin (ng/mL: 65.7±13.5 vs. 45.5±10.5, P<0.001) and PAI-1 (ng/mL: 178.6±32.6 vs. 75.5±21.0, P<0.001), while the level of protein C was significantly lower (%: 45.6±9.6 vs. 56.8±11.3, P<0.001). In coagulation biomarkers, platelet count, FDP, PT, AT Ⅲ, plasminogen and α2-PI in AKI group were significantly different from those in non-AKI group (P<0.05). sTM has high specificity (98%) but limited sensitivity (55%) and AUROC of 0.735 (P<0.001). Multivariate Logistic regression analysis showed that sTM was an independent predictor of AKI (OR: 0.74,95%CI0.35~1.24, P=0.033). Conclusion Endothelial biomarkers change significantly in patients with AKI and sepsis. sTM is an independent predictor of AKI in sepsis that outperforms other coagulation and inflammatory biomarkers and organ function.
|
|
Corresponding Authors:
Xiao Dong, E-mail:xiao1972dong@163.com
|
|
|
|
[1]Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
[2]Kathuria D, Singh NP. Prevention and Management of Acute Kidney Injury: What a Physician Should Know[J]. J Assoc Physicians India, 2017, 65(5): 74-78.
[3]Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study[J]. Intensive Care Med, 2015, 41(8): 1411-1423.
[4]Sakurai K, Miyashita T, Okazaki M, et al. Role for Neutrophil Extracellular Traps (NETs) and Platelet Aggregation in Early Sepsis-induced Hepatic Dysfunction[J]. In Vivo, 2017, 31(6): 1051-1058.
[5]Matejovic M, Valesova L, Benes J, et al. Molecular differences in susceptibility of the kidney to sepsis-induced kidney injury[J]. BMC Nephrol, 2017, 18(1): 183.
[6]Lin SM, Wang YM, Lin HC, et al. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis[J]. Crit Care Med, 2008, 36(3): 683-689.〖LL〗
[7]Umbro I, Gentile G, Tinti F, et al. Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury[J]. J Infect, 2016, 72(2): 131-142.
[8]Powell TC, Powell SL, Allen BK, et al. Association of inflammatory and endothelial cell activation biomarkers with acute kidney injury after sepsis[J]. Springerplus, 2014, 3: 207.
[9]Su CM, Cheng HH, Hung CW, et al. The value of serial serum cell adhesion molecules in predicting acute kidney injury after severe sepsis in adults[J]. Clin Chim Acta, 2016, 457: 86–91.〖ZK)〗
[10]Bouchard J, Malhotra R, Shah S,et al. Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study[J]. PLoS One, 2015, 10(3): e0120 770.
[11]Liu KL, Lee KT, Chang CH, et al. Elevated plasma thrombomodulin and angiopoietin-2 predict the development of acute kidney injury in patients with acute myocardial infarction[J]. Crit Care, 2014, 18(3):R100.
[12]Kellum JA, Lameire N, KDIGO AK Guideline Work Group. et al. Diagnosis, evaluation,and management of acute kidney injury: a KDIGO summary (Part 1)[J]. Crit Care, 2013, 17(1):204.
[13]Teles F, de Mendona Ucha JV, Mirelli Barreto Mendona D, et al. Acute kidney injury in leptospirosis: the Kidney Disease Improving Global Outcomes (KDIGO) criteria and mortality[J]. Clin Nephrol, 2016, 86(12): 303-309.
[14]Vysakh A, Raji NR, Suma D, et al. Role of antioxidant defence, renal toxicity markers and inflammatory cascade in disease progression of acute pyelonephritis in experimental rat model[J]. Microb Pathog, 2017, 109: 189-194.
[15]Yang CC, Yip HK, Chen KH, et al. Impact of impaired cardiac function on the progression of chronic kidney disease-role of pharmacomodulation of valsartan[J]. Am J Transl Res, 2017, 9(5): 2548-2566.
[16]Pan B, Wang X, Kojima S, et al. The fifth epidermal growth factor like region of thrombomodulin alleviates LPS-induced sepsisthrough interacting with GPR15[J]. Thromb Haemost, 2017, 117(3): 570-579.
[17]Arioka T, Tawara S, Sata M, et al. Thrombomodulin alfa attenuates thrombin-induced leakage of antithrombin through suppression of endothelial vascular hyperpermeability[J]. Thromb Res, 2017, 157: 170-172.
[18]Hayakawa M, Kushimoto S, Watanabe E, et al. Pharmacokinetics of recombinant human soluble thrombomodulin in disseminated intravascular coagulation patients with acute renal dysfunction[J]. Thromb Haemost, 2017, 117(5): 851-859.
[19]Takehara K, Murakami T, Kuwahara AK, et al. Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharideinduced murinesepsis model[J]. Exp Ther Med, 2017, 13(6): 2969-2974.
[20]Koyama K, Madoiwa S, Nunomiya S, et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study[J]. Crit Care, 2014, 18(1): R13.
[21]Itenov TS, Jensen JU, Ostrowski SR, et al. Endothelial Damage Signals Refractory Acute Kidney Injury in Critically Ill Patients[J]. Shock, 2017, 47(6): 696-701. |
|
|
|